Selected research
Industry Research
Flutamide Industry Research Report 2026
Market perspective
The global Flutamide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Flutamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Flutamide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Flutamide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Flutamide include Tasly Diyi Pharma, Forward, SANDOZ, Merck, TEVA Pharma, Florencia Healthcare, Cipla LifeScience and Actiza Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Flutamide market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Flutamide Market by Company
Tasly Diyi Pharma
Forward
SANDOZ
Merck
TEVA Pharma
Florencia Healthcare
Cipla LifeScience
Actiza Pharma
Flutamide Segment by Type
Flutamide Tablets
Flutamide Capsule
Others
Flutamide Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Flutamide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flutamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Flutamide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flutamide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Flutamide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Flutamide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Flutamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Flutamide Tablets
- Flutamide Capsule
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Tasly Diyi Pharma
- Forward
- SANDOZ
- Merck
- TEVA Pharma
- Florencia Healthcare
- Cipla LifeScience
- Actiza Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Flutamide Market Size (2021-2032)
- 2.2.2 Global Flutamide Sales (2021-2032)
- 2.2.3 Global Flutamide Market Average Price (2021-2032)
- 2.3 Flutamide by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Flutamide Tablets
- 2.3.3 Flutamide Capsule
- 2.3.4 Others
- 2.4 Flutamide by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Flutamide Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Flutamide Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Flutamide Revenue of Manufacturers (2021-2026)
- 3.4 Global Flutamide Average Price by Manufacturers (2021-2026)
- 3.5 Global Flutamide Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Flutamide, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Flutamide, Product Type & Application
- 3.8 Global Manufacturers of Flutamide, Established Date
- 3.9 Global Flutamide Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Tasly Diyi Pharma
- 4.1.1 Tasly Diyi Pharma Company Information
- 4.1.2 Tasly Diyi Pharma Business Overview
- 4.1.3 Tasly Diyi Pharma Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Tasly Diyi Pharma Flutamide Product Portfolio
- 4.1.5 Tasly Diyi Pharma Recent Developments
- 4.2 Forward
- 4.2.1 Forward Company Information
- 4.2.2 Forward Business Overview
- 4.2.3 Forward Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Forward Flutamide Product Portfolio
- 4.2.5 Forward Recent Developments
- 4.3 SANDOZ
- 4.3.1 SANDOZ Company Information
- 4.3.2 SANDOZ Business Overview
- 4.3.3 SANDOZ Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 SANDOZ Flutamide Product Portfolio
- 4.3.5 SANDOZ Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Flutamide Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 TEVA Pharma
- 4.5.1 TEVA Pharma Company Information
- 4.5.2 TEVA Pharma Business Overview
- 4.5.3 TEVA Pharma Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 TEVA Pharma Flutamide Product Portfolio
- 4.5.5 TEVA Pharma Recent Developments
- 4.6 Florencia Healthcare
- 4.6.1 Florencia Healthcare Company Information
- 4.6.2 Florencia Healthcare Business Overview
- 4.6.3 Florencia Healthcare Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Florencia Healthcare Flutamide Product Portfolio
- 4.6.5 Florencia Healthcare Recent Developments
- 4.7 Cipla LifeScience
- 4.7.1 Cipla LifeScience Company Information
- 4.7.2 Cipla LifeScience Business Overview
- 4.7.3 Cipla LifeScience Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Cipla LifeScience Flutamide Product Portfolio
- 4.7.5 Cipla LifeScience Recent Developments
- 4.8 Actiza Pharma
- 4.8.1 Actiza Pharma Company Information
- 4.8.2 Actiza Pharma Business Overview
- 4.8.3 Actiza Pharma Flutamide Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Actiza Pharma Flutamide Product Portfolio
- 4.8.5 Actiza Pharma Recent Developments
5 Global Flutamide Market Scenario by Region
- 5.1 Global Flutamide Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Flutamide Sales by Region: 2021-2032
- 5.2.1 Global Flutamide Sales by Region: 2021-2026
- 5.2.2 Global Flutamide Sales by Region: 2027-2032
- 5.3 Global Flutamide Revenue by Region: 2021-2032
- 5.3.1 Global Flutamide Revenue by Region: 2021-2026
- 5.3.2 Global Flutamide Revenue by Region: 2027-2032
- 5.4 North America Flutamide Market Facts & Figures by Country
- 5.4.1 North America Flutamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Flutamide Sales by Country (2021-2032)
- 5.4.3 North America Flutamide Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Flutamide Market Facts & Figures by Country
- 5.5.1 Europe Flutamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Flutamide Sales by Country (2021-2032)
- 5.5.3 Europe Flutamide Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Flutamide Market Facts & Figures by Country
- 5.6.1 Asia Pacific Flutamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Flutamide Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Flutamide Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Flutamide Market Facts & Figures by Country
- 5.7.1 South America Flutamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Flutamide Sales by Country (2021-2032)
- 5.7.3 South America Flutamide Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Flutamide Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Flutamide Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Flutamide Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Flutamide Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Flutamide Sales by Type (2021-2032)
- 6.1.1 Global Flutamide Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Flutamide Sales Market Share by Type (2021-2032)
- 6.2 Global Flutamide Revenue by Type (2021-2032)
- 6.2.1 Global Flutamide Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Flutamide Revenue Market Share by Type (2021-2032)
- 6.3 Global Flutamide Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Flutamide Sales by Application (2021-2032)
- 7.1.1 Global Flutamide Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Flutamide Sales Market Share by Application (2021-2032)
- 7.2 Global Flutamide Revenue by Application (2021-2032)
- 7.2.1 Global Flutamide Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Flutamide Revenue Market Share by Application (2021-2032)
- 7.3 Global Flutamide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Flutamide Value Chain Analysis
- 8.1.1 Flutamide Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Flutamide Production Mode & Process
- 8.2 Flutamide Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Flutamide Distributors
- 8.2.3 Flutamide Customers
9 Global Flutamide Analyzing Market Dynamics
- 9.1 Flutamide Industry Trends
- 9.2 Flutamide Industry Drivers
- 9.3 Flutamide Industry Opportunities and Challenges
- 9.4 Flutamide Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst